Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-10-016362

Options or other derivatives

  • Director acquired 171,792 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

STALDER RUEDI · Director

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-11-17 Grant or award : show line 1 in the form Common Stock Option +71,792 $0.26 2020-11-17 71,792 981,743 D
2010-11-17 Grant or award : show line 2 in the form Common Stock Option +100,000 $0.26 2020-11-17 100,000 1,081,743 D
Loading xslF345X03/edgar.xml…